Novimmune SA (Novimmune)

Oncology Corporate Profile

HQ Location

14 Chemin des Aulx
1228 Plan-Les-Ouates
Geneva, Switzerland

Company Description

Novimmune SA is a Swiss biopharmaceutical company focused on the discovery and development of antibody-based drugs for the targeted treatment of inflammatory diseases, immune-related disorders, and cancer.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
NI-1701CD47/CD19 inhibitorVarious cancer typesPreclinical

View additional information on product candidates here »


Recent News Headlines

There are no news items to display